Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Fruhwald, FM; Kjellström, B; Perthold, W; Wonisch, M; Maier, R; Klein, W.
Hemodynamic observations in two pulmonary hypertensive patients changing treatment from inhaled iloprost to the oral endothelin-antagonist bosentan.
J HEART LUNG TRANSPLANT. 2005; 24(5): 631-634.
Doi: 10.1016/j.healun.2004.03.001
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Fruhwald Friedrich
- Co-Autor*innen der Med Uni Graz
-
Maier Robert
-
Wonisch Manfred
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Two female patients with pulmonary arterial hypertension and a permanently implanted hemodynamic monitor changed treatment from inhaled iloprost to oral bosentan. The hemodynamic changes were seen very early after the first dose of bosentan and there was no need to re-establish inhaled iloprost.
- Find related publications in this database (using NLM MeSH Indexing)
-
Administration, Inhalation -
-
Administration, Oral -
-
Adult -
-
Antihypertensive Agents - administration and dosage
-
Female - administration and dosage
-
Hemodynamic Processes - drug effects
-
Humans - drug effects
-
Hypertension, Pulmonary - drug therapy
-
Iloprost - administration and dosage
-
Middle Aged - administration and dosage
-
Monitoring, Ambulatory - instrumentation
-
Prostheses and Implants - instrumentation
-
Receptors, Endothelin - antagonists and inhibitors
-
Sulfonamides - administration and dosage